GURUFOCUS.COM » STOCK LIST » Financial Services » Asset Management » Big Pharma Split Corp (TSX:PRM.PR.A.PFD) » Definitions » Market Cap

Big Pharma Split (TSX:PRM.PR.A.PFD) Market Cap : C$0.00 Mil (As of Apr. 27, 2024)


View and export this data going back to 2017. Start your Free Trial

What is Big Pharma Split Market Cap?

Market cap is the total market value to buy the whole company. It is equal to the share price times the number of Shares Outstanding (EOP). Big Pharma Split's share price for the quarter that ended in Dec. 2023 was C$0. Big Pharma Split's Shares Outstanding (EOP) for the quarter that ended in Dec. 2023 was 0.00 Mil. Therefore, Big Pharma Split's market cap for the quarter that ended in Dec. 2023 was C$ Mil.

Enterprise Value is the theoretical takeover price. It is more comprehensive than market capitalization (market cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash and cash equivalents. Big Pharma Split's Enterprise Value for Today is C$0.00 Mil.


Big Pharma Split Market Cap Historical Data

The historical data trend for Big Pharma Split's Market Cap can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Big Pharma Split Market Cap Chart

Big Pharma Split Annual Data
Trend Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Market Cap
Get a 7-Day Free Trial - - - - -

Big Pharma Split Semi-Annual Data
Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
Market Cap Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of Big Pharma Split's Market Cap

For the Asset Management subindustry, Big Pharma Split's Market Cap, along with its competitors' market caps and Market Cap data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Big Pharma Split's Market Cap Distribution in the Asset Management Industry

For the Asset Management industry and Financial Services sector, Big Pharma Split's Market Cap distribution charts can be found below:

* The bar in red indicates where Big Pharma Split's Market Cap falls into.



Big Pharma Split Market Cap Calculation

Market cap is the short version of market capitalization. It is the total market value to buy the whole company. It is equal to the share price times the number of shares outstanding.

Big Pharma Split's Market Cap for the fiscal year that ended in Dec. 2023 is calculated as

Market Cap (A: Dec. 2023 )=Share Price (A: Dec. 2023 )*Shares Outstanding (EOP) (A: Dec. 2023 )
=C$0*0
=C$

Big Pharma Split's Market Cap for the quarter that ended in Dec. 2023 is calculated as

Market Cap (Q: Dec. 2023 )=Share Price (Q: Dec. 2023 )*Shares Outstanding (EOP) (Q: Dec. 2023 )
=C$0*0
=C$

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Big Pharma Split  (TSX:PRM.PR.A.PFD) Market Cap Explanation

Market cap is not the real price you pay for a company. If you buy the company and become its owner, you become the owner of the cash the company has, and you also assume the company’s debt. The real price you pay is the Enterprise Value.

Warren Buffett uses the ratio of total market cap of all public traded companies over GDP to measure if the market is expensive. As of April 2012, the US total market cap is about $14.7 trillion, while the US GDP is about $15 trillion. The market was modestly overvalued.


Big Pharma Split Market Cap Related Terms

Thank you for viewing the detailed overview of Big Pharma Split's Market Cap provided by GuruFocus.com. Please click on the following links to see related term pages.


Big Pharma Split (TSX:PRM.PR.A.PFD) Business Description

Traded in Other Exchanges
Address
610 Chartwell Road, Suite 204, Oakville, ON, CAN, L6J 4A5
Big Pharma Split Corp is a mutual fund corporation. Its investment objective is to provide shareholders with fixed cumulative preferential quarterly cash distributions, and regular monthly cash distributions. The company has a presence in the United States; Switzerland; France and United Kingdom.

Big Pharma Split (TSX:PRM.PR.A.PFD) Headlines

No Headlines